Laxmi Dental working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025
89.72×89.72×118.92×
54.00×54.00×55.99×
94.91×94.91×204.43×
48.81×48.81×−29.52×
1.79×1.73×1.83×
0.96×0.96×0.84×
−0.17×−0.17×1.38×
−0.12×−0.12×1.05×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LAXMIDENTL₹177.37

Laxmi Dental Limited

· Pharma & Health
₹ CrorePeersFABTECHTARSONSFISCHERGKBMcap ₹975 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)118.9289.7289.72
Receivable Days (DSO)55.9954.0054.00
Payable Days (DPO)204.4394.9194.91
Cash Conversion Cycle (days)-29.5248.8148.81
Working Capital Turnover1.831.731.79
Asset Turnover0.840.960.96
Cash Conversion (CFO/Net Income)1.38-0.17-0.17
CFO/EBITDA1.05-0.12-0.12
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.